Connect with us

Technology

Leveraging EMR/EHR Data and Patient Engagement to Maximize Clinical Trial Recruitment, Upcoming Webinar Hosted by Xtalks

Published

on

In this free webinar, learn how to maximize clinical trial recruitment through electronic medical record (EMR) data and personalized engagement. Attendees will learn how current limitations within research sites and the trial process hinder effective patient recruitment and enrollment efforts. The featured speakers will discuss how, despite privacy and security concerns, EMR queries can revolutionize how we recruit, engage and enroll participants in clinical trials. The speakers will also share how meaningful conversations and tailored education are key to helping participants understand trial benefits and make informed decisions about enrollment. Attendees will learn how leveraging new data, technology and services offers practical ways to overcome longstanding issues in clinical research recruitment and engagement.

TORONTO, Oct. 29, 2024 /PRNewswire-PRWeb/ — Maximizing Recruitment Through EMR Data and Personalized Engagement

An important piece is the human touch — the conversations that help patients understand how clinical research might benefit them personally or serve the greater good for others living with similar conditions.

One of the core challenges in clinical research is recruiting the right participants. Various outreach methods, including recruitment advertising and physician referrals, are critical but often insufficient in isolation. This is where integrating electronic medical record (EMR) queries comes into play. EMR queries can be a great starting point for identifying suitable participants, and when followed by meaningful engagement, enrollment can be achieved more effectively.

While it is well known that EMR/electronic health record (EHR) data can match patients to clinical trials, data alone does not close the gap. An important piece is the human touch — the conversations that help patients understand how clinical research might benefit them personally or serve the greater good for others living with similar conditions.

In this webinar, the expert speakers discuss patient identification and the steps that follow in the participant journey to ensure researchers are meeting enrollment goals in clinical trials. The panel provides their perspectives on the barriers across clinical research sites and throughout the trial process while discussing how patient EMR data can effectively address these challenges. Additionally, they will explore the various data, technology and services that can create actionable solutions, including the implications of consolidation within the patient EMR space and its significance for pharmaceutical sponsors.

This webinar will be advantageous for those interested in learning more about the potential of EMR/EHR data throughout the clinical research process, who want to hear first-hand insights from leaders throughout the pharmaceutical industry or who wish to gain a better understanding of how we can all work together to solve the historical issues surrounding research engagement and the cutting-edge applications of healthcare data as part of the solution.

Register for this webinar today to discover how integrating EMR data with personalized patient engagement strategies can transform recruitment in clinical trials.

Join Irfan Khan (Moderator), MD, CEO, Circuit Clinical; Kelly McKee, Head of Innovative Patient Recruitment, Evinova, AstraZeneca; Scott Gucciardi, SVP/GM, Connectivity, Insights, and VBC Businesses, NextGen Healthcare; Meghna Wolfe, Manager of Business Partner Relations, NextGen Healthcare; and Kathy Bean, RHIA, CHPS, Vice President of Technology & Clinical Informatics, Circuit Clinical, for the live webinar on Tuesday, November 19, 2024, at 2pm EST (11am PST).

For more information, or to register for this event, visit Leveraging EMR/EHR Data and Patient Engagement to Maximize Clinical Trial Recruitment.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars and digital content to the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps professionals stay current with industry developments, regulations and jobs. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit https://xtalks.com
For information about hosting a webinar visit https://xtalks.com/why-host-a-webinar/

Contact:
Vera Kovacevic
Tel: +1 (416) 977-6555 x371
Email: vkovacevic@xtalks.com

Media Contact

Vera Kovacevic, Xtalks, +1 (416) 977-6555 x371, vkovacevic@xtalks.com, www.xtalks.com

View original content to download multimedia:https://www.prweb.com/releases/leveraging-emrehr-data-and-patient-engagement-to-maximize-clinical-trial-recruitment-upcoming-webinar-hosted-by-xtalks-302290184.html

SOURCE Xtalks

Continue Reading

Technology

LEAP Group Relaunches HumanView, a Growth Intelligence System Built to Explain Why Customers Behave the Way They Do

Published

on

By

Reimagined from the ground up, HumanView pairs statistical modeling with expert analysts to turn millions of real-world customer signals into business decisions

LOUISVILLE, Ky., Oct. 23, 2026 /PRNewswire/ — LEAP Group today announced the relaunch of HumanView, its growth intelligence service. The new version has been rebuilt from the ground up and now has a dedicated home at leapgroupnetwork.com/humanview.

HumanView analyzes what customers say and do across social platforms, e-commerce sites, review platforms, search behavior and user-generated content, including signals from Reddit, TikTok, YouTube, Meta, Amazon and Walmart+ that general AI tools cannot always access. Because the data reflects unprompted, real-world behavior, it avoids the response bias built into surveys and focus groups.

The service works in three layers. HumanView captures signals at scale, decodes millions of records through validated statistical models such as regression, correlation and clustering, and then relies on experienced analysts to interpret the patterns. Clients receive clear, human-validated insights instead of another dashboard.

“Machines find the patterns. Humans find the point,” said Alan Gilleo, CEO at LEAP Group. “The first version of HumanView showed us how much customers reveal when nobody is asking them questions. This version is built to explain why they act the way they do, and to put those answers in front of everyone making decisions, from product to service to marketing.”

HumanView focuses on three areas:

Growth Intelligence: customer motivations and how people perceive a brand and its competitors

Market and Category Intelligence: product pain points, service friction, unmet needs and competitive gaps

Audience Intelligence: new segments, positioning opportunities and gaps in the market

Every model is designed and validated by data scientists and benchmarked before it informs a recommendation.

To learn more about HumanView, visit leapgroupnetwork.com/humanview.

About LEAP Group
LEAP Group is a boutique marketing agency holding company with offices in Louisville, Indianapolis, Cincinnati and Chicago. Guided by the belief that brands should “Market Less. Matter More.,” LEAP gives clients access to specialized experts across its entire network. Learn more at leapgroupnetwork.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/leap-group-relaunches-humanview-a-growth-intelligence-system-built-to-explain-why-customers-behave-the-way-they-do-302918557.html

SOURCE LEAP Group

Continue Reading

Technology

STEPHEN A. SMITH ADDRESSES WHITE HOUSE DINNER ATTENDANCE, REAFFIRMS COMMITMENT TO HBCUs AND PROTECTING CORPORATE INVESTMENT IN BLACK EDUCATION

Published

on

By

NEW YORK, Oct. 23, 2026 /PRNewswire/ — Stephen A. Smith, media mogul, New York Times bestselling author, and proud 1991 graduate of Winston-Salem State University, is addressing the public discussion surrounding his decision to attend a White House dinner with President Donald Trump, emphasizing his commitment to the long-term financial stability of Historically Black Colleges and Universities (HBCUs).

For Smith, the decision was rooted in a commitment to institutions that have educated generations of Black leaders, professionals, entrepreneurs, and public servants.

“I will always advocate for HBCUs and the students whose futures depend on them,” Smith said. “My reason for attending the White House dinner was to discuss the challenges these institutions face in securing long-term funding and to make the case that corporate America must continue to invest in them.”

Smith acknowledged federal support through the FUTURE Act while expressing concern that political tensions surrounding diversity, equity, and inclusion (DEI) could discourage private companies from supporting HBCUs. He maintains that these institutions deserve sustained corporate partnerships, philanthropic contributions, and public investment.

“If we truly believe in free-market capitalism, businesses should be able to support educational institutions and charitable causes without fear of criticism or repercussions,” Smith said. “HBCUs have made extraordinary contributions to this country. They deserve sustained public and private investment.”

Ashley Christopher, Esq., Founder and CEO of the HBCU Week Foundation, recognized Smith’s advocacy and decision to engage with the administration.

“Stephen A. Smith has been a powerful advocate for HBCUs, using his platform and influence to shine a national spotlight on our institutions,” expressed Christopher, “His continued support of HBCU Week helps advance our mission of connecting students with life-changing educational opportunities, and we are proud to have him as our ambassador.”

Since Smith became an HBCU Week Ambassador in 2019, the initiative has facilitated more than 15,000 on-the-spot college acceptances and raised and awarded more than $150 million in scholarships, according to the HBCU Week Foundation.

As public discussion continues, Smith is emphasizing the importance of ensuring HBCUs have the resources and partnerships needed to educate future generations and expand opportunities for students.

CLICK HERE to watch Smith’s full response to his White House visit.

MEDIA CONTACT:

media@mrsasinc.com

View original content:https://www.prnewswire.com/news-releases/stephen-a-smith-addresses-white-house-dinner-attendance-reaffirms-commitment-to-hbcus-and-protecting-corporate-investment-in-black-education-302918547.html

SOURCE Straight Shooter Media

Continue Reading

Technology

Advantex Announces Completion of Financing and Extension of Maturity Date of Previously Issued Debentures

Published

on

By

TORONTO, Oct. 23, 2026 /CNW/ — Advantex Marketing International Inc. (CSE: ADX) (“Advantex”), a leader in the merchant cash advance and loyalty marketing products for merchants, today announced the completion of a $250,000 secured debt financing. Advantex issued a $250,000 non-convertible debenture which bears an interest rate at 12% per annum and matures December 15, 2027. The proceeds raised from this issuance of the Debenture will be used for working capital purposes.

Advantex has also extended the maturity of its existing $700,000 in 12% secured debentures from October 10, 2026 to December 15, 2027.

About Advantex Marketing International Inc.

Advantex provides working capital to merchants. Advantex also provides specialized marketing programs that enable members of Aeroplan to earn Aeroplan points at participating merchants.

Advantex shares trade on the Canadian Securities Exchange under the symbol ADX. For more information go to Advantex’s profile on www.sedar.com

Forward-Looking Information

This news release contains “forward-looking statements” within the meaning of applicable securities laws relating to the future business and operations of Advantex. Actual results and developments may differ materially from those contemplated by these statements. The business and operations of Advantex described herein is dependent on a number of factors and is subject to a number of risks and uncertainties. Factors that could cause actual results to differ material include, but are not limited to, changes in Advantex’s economic and competitive conditions including but not limited to the industry sectors in which Advantex operates.

The statements in this news release are made of the date of this release. Forward-looking statements are made based on management’s beliefs, estimates and opinions on the date the statements are made and Advantex undertakes no obligation to update forward-looking statements if these beliefs, estimates and opinions or other circumstances should change, except as required by applicable law.

SOURCE Advantex Marketing International Inc.

Continue Reading

Trending